Floatz logo

Therapeutic Asset Ratings

686 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ERIBULIN MONOMETHANESULFONATE
Breast Cancer
Henan Cancer HospitalP4BB (69)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Breast Cancer
SWOG Cancer Research NetworkP4BB (69)
Palbociclib
Breast Cancer
Hoffmann-La RocheP4BB (69)
TAMOXIFEN
Breast Cancer
Dana-Farber Cancer InstituteP4BB (69)
VITAMIN D
Breast Cancer
University of Illinois at ChicagoP4BB (69)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Breast Cancer
Ospedale di CamposampieroP4BB (68)
Eloxatin
Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.P4BB (68)
FLUOROURACILUM
Breast Cancer
PfizerP4BB (68)
Inno-206
Breast Cancer
George Washington UniversityP4BB (68)
Ribociclib
Breast Cancer
National Cancer Institute (NCI)P4BB (68)
Zoladex
Breast Cancer
TerSera Therapeutics LLCP4BB (68)
Arimidex
Breast Cancer
National Cancer Institute (NCI)P4BB (67)
Capecitabine
Breast Cancer
University of Vermont Medical CenterP4BB (67)
Carboplatin
Breast Cancer
AkesoP4BB (67)
Cyclophosphamide
Breast Cancer
Fudan UniversityP4BB (67)
Docetaxel
Breast Cancer
Fudan UniversityP4BB (67)
Epirubicin
Breast Cancer
Ohio State University Comprehensive Cancer CenterP4BB (67)
Eribulin
Breast Cancer
Sun Yat-sen UniversityP4BB (67)
Everolimus
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP4BB (67)
EXEMESTANE
Breast Cancer
National Cancer Institute (NCI)P4BB (67)
FILGRASTIM
Breast Cancer
MedSIRP4BB (67)
FULVESTRANT
Breast Cancer
MedSIRP4BB (67)
Irinotecan
Breast Cancer
PfizerP4BB (67)
Letrozole
Breast Cancer
National Cancer Institute (NCI)P4BB (67)
LEUPROLIDE
Breast Cancer
Fudan UniversityP4BB (67)
Showing 1 to 25 of 686 assets
PreviousPage 1 of 28Next